3648 results for «2450»

Filter By

3648 results

Taking on the tough stuff: TAVI in complex anatomies

21 May 2026 – From EuroPCR 2026

Focused on the challenges of transcatheter aortic valve implantation (TAVI) in complex anatomies, this session addresses optimal strategies for treating bicuspid aortic valve stenosis, managing small annuli and low coronary ostia, and approaches to degenerated surgical valves including bioprosthetic fracture techniques. Case-based discussions elucidate practical solutions...

Taking on the tough stuff: TAVI in complex anatomies

Is there a rule for DCB in ACS setting?

22 May 2026 – From EuroPCR 2026

This session examines the application of drug-coated balloons (DCB) in the acute coronary syndrome (ACS) setting, comparing outcomes with drug-eluting stents (DES). It discusses the impact of intraluminal thrombus, real-world registry data on DCB-first strategies in STEMI, and multicentre experiences with DCB use in STEMI and...

DCB: what we know and what we do not know

22 May 2026 – From EuroPCR 2026

This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.

DCB: what we know and what we do not know

How should I treat my CTO? Adapting to local conditions

22 May 2026 – From EuroPCR 2026

This session delves into managing chronic total occlusions (CTO) under resource-limited conditions, highlighting the essential CTO toolbox and strategic procedural planning. It emphasizes that an antegrade-first approach, often with dual arterial access, can achieve high success in many CTO cases, illustrated through complex real-world cases from...

Complex anatomy in STEMI patients

19 May 2026 – From EuroPCR 2026

This session addresses the unique challenges posed by complex coronary anatomy in STEMI patients. Through detailed case discussions, it highlights management of anomalous culprit origins, multifaceted infarcts, rare presentations, and urgent primary PCI strategies in anatomically complex scenarios. The session emphasizes adaptive techniques to navigate unexpected...

When a primary PCI goes wrong

19 May 2026 – From EuroPCR 2026

This session investigates complications encountered during primary percutaneous coronary interventions (PCI). It covers management of no-reflow phenomena, innovative guide extension catheter aspiration techniques for thrombus-rich STEMI, challenges when balloon crossing fails, vein graft PCI pitfalls, and complex concurrent ischemic events involving myocardial infarction and limb ischemia....

Regulatory and reimbursement pathways for MedTech innovators

19 May 2026 – From EuroPCR 2026

This session provides an in-depth exploration of regulatory and reimbursement pathways critical for MedTech innovators. It covers the transition challenges from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR), sharing lessons learned and success stories. The session also addresses reimbursement frameworks in the...

The thin line between success and failure in MedTech start ups - Lessons learnt

18 May 2026 – From EuroPCR 2026

This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.

Transcatheter mitral valve replacement - LIVE case

20 May 2026 – From EuroPCR 2026

A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).

A transcatheter mitral...

Transcatheter mitral valve replacement - LIVE case

New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices

20 May 2026 – From EuroPCR 2026

This session explores new frontiers in transcatheter aortic valve implantation (TAVI) for treating pure aortic regurgitation. It addresses the challenges inherent to this indication, reviews treatment approaches using conventional balloon-expandable and self-expandable devices, and presents recent data along with dedicated TAVI devices designed specifically for aortic...

New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices

Strategical approaches to treat patients with multivessel disease

20 May 2026 – From EuroPCR 2026

This comprehensive session focuses on strategic approaches to manage patients with multivessel coronary artery disease. It covers a spectrum of topics including ostial stent implantation techniques, the impact of center volume on CT-guided angiography post-CABG, and physiology-guided PCI versus angiography alone. Insights into percutaneous revascularisation strategies...

Management of stable CAD

20 May 2026 – From EuroPCR 2026

This session provides an in-depth review of current management strategies for stable coronary artery disease (CAD). Topics include angiographic predictors influencing PCI efficacy in stable angina, comparative outcomes of immediate versus staged PCI, and analyses of treatment approaches for significant left anterior descending artery disease. The...

Managing complex calcified PCI: pitfalls and complications

20 May 2026 – From EuroPCR 2026

This session addresses the complexities and challenges of performing PCI in heavily calcified coronary lesions. Emphasizing the critical role of imaging in procedural planning, it updates on contemporary tools and techniques to mitigate complications. The session also shares practical experience in managing common complications such as...

Managing complex calcified PCI: pitfalls and complications

Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)

20 May 2026 – From EuroPCR 2026

This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the...

Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)

Rescue techniques for coronary interventions

20 May 2026 – From EuroPCR 2026

This session presents an array of advanced rescue techniques employed in coronary interventions when unexpected complications arise. It features real-world cases including management of complex coronary artery aneurysms, malignant pericardial tamponade, challenging primary PCI scenarios, and innovative bailout strategies such as self-made covered stents and guidewire...

Rescue techniques for

Back to the future - Lessons from the past that can guide contemporary practice

20 May 2026 – From EuroPCR 2026

Reflecting on historical perspectives in the management of atherosclerotic coronary vascular disease, this session imparts valuable lessons to guide contemporary PCI practice. It emphasizes best practices in vessel preparation, evaluates the significance of drug-eluting stents, and provides a pathologist’s insight into mechanisms of PCI failure to...

Back to the future - Lessons from the past that can guide contemporary practice

A critical appraisal of the recent evidence in the LAA closure field

20 May 2026 – From EuroPCR 2026

This session critically appraises recent evidence in the left atrial appendage (LAA) closure field, focusing on landmark trials such as CHAMPION-AF and CLOSURE AF. It discusses how these findings may influence patient selection and clinical practice, offering guidance on integrating new evidence into decision-making for stroke...

A critical appraisal of the recent evidence in the LAA closure field

Rethinking coronary artery disease: from ischaemia to atheroma - Implications of the Lancet Commission for Interventional Cardiology

20 May 2026 – From EuroPCR 2026

This session invites a re-evaluation of coronary artery disease by shifting focus from ischemia to atheroma, integrating insights from the Lancet Commission for Interventional Cardiology. It explores the significance of plaque burden, biology, and inflammation in guiding PCI decisions and outlines the future role of PCI...

TAVI procedural complications - Part 4: vascular complications, coronary issues and more

20 May 2026 – From EuroPCR 2026

This session addresses a spectrum of procedural complications encountered in TAVI, focusing on vascular issues, coronary challenges, and device-related difficulties. Case presentations include partial prosthesis expansion, emergency thoracic aortic stenting, repeat balloon valvuloplasty, revascularization dilemmas, and complex valve-in-valve procedures. The discussion provides practical perspectives on managing...

The value of intravascular imaging in the planning - Optimisation of PCI and dealing with complications

20 May 2026 – From EuroPCR 2026

Highlighting the critical role of intravascular imaging in PCI, this session explores its utility in procedural planning, optimization of outcomes, and identification and management of complications. Through international case studies, it demonstrates how imaging enhances understanding beyond angiography alone and facilitates tailored, effective interventions.

Didn’t find what you were looking for?